KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Boston Scientific (BSX) Change in Inventory (2020 - 2025)

Boston Scientific's Change in Inventory history spans 6 years, with the latest figure at $50.0 million for Q4 2025.

  • For Q4 2025, Change in Inventory rose 208.7% year-over-year to $50.0 million; the TTM value through Dec 2025 reached $188.0 million, down 17.54%, while the annual FY2025 figure was $188.0 million, 17.54% down from the prior year.
  • Change in Inventory for Q4 2025 was $50.0 million at Boston Scientific, down from $94.0 million in the prior quarter.
  • Across five years, Change in Inventory topped out at $215.0 million in Q3 2021 and bottomed at -$65.0 million in Q2 2025.
  • The 5-year median for Change in Inventory is $94.5 million (2022), against an average of $87.1 million.
  • The largest annual shift saw Change in Inventory soared 714.29% in 2021 before it tumbled 177.97% in 2024.
  • A 5-year view of Change in Inventory shows it stood at $31.0 million in 2021, then soared by 48.39% to $46.0 million in 2022, then increased by 28.26% to $59.0 million in 2023, then plummeted by 177.97% to -$46.0 million in 2024, then soared by 208.7% to $50.0 million in 2025.
  • Per Business Quant, the three most recent readings for BSX's Change in Inventory are $50.0 million (Q4 2025), $94.0 million (Q3 2025), and -$65.0 million (Q2 2025).